0001209191-20-002600.txt : 20200108 0001209191-20-002600.hdr.sgml : 20200108 20200108180641 ACCESSION NUMBER: 0001209191-20-002600 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200106 FILED AS OF DATE: 20200108 DATE AS OF CHANGE: 20200108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIM AUSTIN D. CENTRAL INDEX KEY: 0001746240 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 20516667 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-06 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001746240 KIM AUSTIN D. C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, STE. 300 SAN DIEGO CA 92130 0 1 0 0 EVP & General Counsel Stock Options (Right to Buy) 42.81 2020-01-06 4 A 0 23709 0.00 A 2030-01-06 Common Stock 23709 23709 D Restricted Stock Units 2020-01-06 4 A 0 6533 0.00 A Common Stock 6533 6533 D 25% of the shares subject to the Stock Option will vest and become exercisable on January 6, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. The restricted stock units vest in four equal annual installments beginning January 6, 2021. /s/ Austin D. Kim 2020-01-08